Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Hims & Hers vs Virta Health

Hims & Hers
Graded #36

Higher grade

vs+21.299999999999997
Virta Health
Graded #336

Lower grade

The verdict

Hims & Hers takes it — 81/100 to 59.7/100.

Hims & Hers grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Mass-market app-first program with nationwide reach and consumer-grade polish.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueHims & Hers +37
82
45
Dose & formulationHims & Hers +27
78
51
Clinical oversightHims & Hers +5
82
77
Labs & monitoringHims & Hers +9
80
71
FulfillmentHims & Hers +19
84
65
Contract termsHims & Hers +25
80
55
Hims & Hers · left barVirta Health · right bar

The numbers

MetricHims & HersVirta Health
WeighScore81/10059.7/100
GradeB−C
Scorecard rank#36#336
Semaglutide$199/moNot disclosed
TirzepatideNot disclosedNot disclosed
CoverageAll 50 statesCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyYes
Hims & Hers

Graded #36 · B−

Strengths

  • Nationwide
  • Polished app
  • Strong brand trust

Where it loses points

  • Tirzepatide pricing inconsistently disclosed
  • Industry-wide compounding scrutiny
Virta Health

Graded #336 · C

Strengths

  • Offers a Responsible Prescribing track with optimized GLP-1 use
  • Clinically monitored medication off-ramp toward nutrition therapy
  • Nutrition-first model shown to rival GLP-1 weight loss (about 13% at 1 year)
  • Provided at no cost to members through employers and health plans
  • Strong evidence base for diabetes reversal and metabolic health

Where it loses points

  • Primarily a nutrition program; GLP-1s are a secondary track
  • Distributed via employers and health plans, no direct cash-pay
  • Deliberately discourages GLP-1 use for most members
  • GLP-1 access depends on the specific program the plan selects

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard